Eledon Pharmaceuticals to Participate in Guggenheim Securities SMID Cap Biotech Conference
29 janv. 2025 16h05 HE
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals to Participate in Guggenheim SMID Cap Biotech Conference
Organ Transplant Diagnostics Market Size to Surpass USD 12.57 Billion by 2033 | Straits Research
29 janv. 2025 08h25 HE
|
Straits Research Private Limited - Garner Insights
New York, United States, Jan. 29, 2025 (GLOBE NEWSWIRE) -- An organ transplant is a surgical procedure replacing a damaged organ with a healthy one. Diagnostics for organ transplants are clinical...
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2025 Outlook
13 janv. 2025 07h00 HE
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2025 Outlook
Regenerative Medicine Research Report 2024-2031: Approvals for New Regenerative Medicines and Increasing Applications of Regenerative Medicine in Newer Therapy Areas Driving the $37.27 Billion Market
19 déc. 2024 05h24 HE
|
Research and Markets
Dublin, Dec. 19, 2024 (GLOBE NEWSWIRE) -- The "Regenerative Medicine Market Size, Share, Forecast, & Trends Analysis by Product Application End User - Global Forecast to 2031" report has been...
Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results
12 nov. 2024 16h01 HE
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results
Oral Proteins & Peptides Market Research: Semaglutide, Linaclotide, Calcitonin,GLP-1 Receptor Agonist, GEP, CGRP, Diabetes, Gastroenterology, Genetic Disorder - Global Forecast to 2029
08 nov. 2024 11h32 HE
|
Research and Markets
Dublin, Nov. 08, 2024 (GLOBE NEWSWIRE) -- The "Oral Proteins & Peptides Market by Molecule (Semaglutide, Linaclotide, Calcitonin), Drug Class (GLP-1 Receptor Agonist, GEP, CGRP), Therapeutic...
Eledon Pharmaceuticals to Participate in Guggenheim Securities Inaugural Healthcare Innovation Conference
06 nov. 2024 16h05 HE
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals to Participate in Guggenheim Securities Inaugural Healthcare Innovation Conference
Eledon Pharmaceuticals Announces Pricing of $85 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
29 oct. 2024 07h46 HE
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Announces Pricing of $85 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Eledon Pharmaceuticals Announces Positive Initial Data from Subjects with Type 1 Diabetes Treated with Tegoprubart as Part of an Immunosuppression Regimen Following Islet Transplantation in Investigator-Initiated Trial at UChicago Medicine
29 oct. 2024 07h45 HE
|
Eledon Pharmaceuticals, Inc.
Eledon Announces Positive Initial Data from Subjects with Type 1 Diabetes Treated with Tegoprubart as Part of Regimen Following Islet Transplantation
Renown Health Welcomes First Kidney Transplant Surgeon & Chief of Transplant Surgery Program
10 oct. 2024 14h42 HE
|
Renown Health
Reno, NEV., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Renown Health announces the appointment of Ernesto P. Molmenti, M.D., PH.D. M.B.A. as the hospital’s inaugural kidney transplant surgeon, Chief of...